SCHEMBL28235232

SCHEMBL28235232

C=CCOC(=O)C(CCC)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.49
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
KCNQ2 O43526 1/20 0.40
CHRM1 P11229 1/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10948428 0.89 TSHR (0.47) CYP2C19CYP3A4ALDH1A1TSHRSMN1; SMN2
SCHEMBL27481393 0.87 ESR1 (0.43) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL7038420 0.82 POLB (0.54) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL23027213 0.82 POLB (0.54) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL9879547 0.81 CYP3A4 (0.43) CYP3A4ALDH1A1TSHRHSD17B10PKM
Methyl Alcohol SCHEMBL11778530 0.81 CHRM1 (0.58) CYP2C19CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL28333199 0.80 CYP1A2 (0.47) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL9879148 0.80 ALDH1A1 (0.50) CYP3A4ALDH1A1TSHRHSD17B10PKM
SCHEMBL28110882 0.80 CYP2C19 (0.50) CYP2C19CYP3A4CYP1A2CYP2D6ALDH1A1
SCHEMBL2293835 0.80 CYP1A2 (0.47) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108367043-A The conjugate of quaternized tubulysin compound 西雅图基因公司 2018-08-03 CN disclosed